Navigation Links
Barr Announces Favorable Ruling in Mirapex(R) Patent Challenge
Date:6/26/2008

he Hatch-Waxman Act. In March 2008, the patent infringement case was heard in front of Judge Farnan.

Mirapex (pramipexole dihydrochloride) had annualized sales of approximately $381 million for the twelve months ended April 2008, based on IMS sales data.

About Barr Pharmaceuticals, Inc.

Barr Pharmaceuticals, Inc. is a global specialty pharmaceutical company that operates in more than 30 countries worldwide and is engaged in the development, manufacture and marketing of generic and proprietary pharmaceuticals, biopharmaceuticals and active pharmaceutical ingredients. A holding company, Barr operates through its principal subsidiaries: Barr Laboratories, Inc., Duramed Pharmaceuticals, Inc. and PLIVA d.d. and its subsidiaries. The Barr Group of companies markets more than 120 generic and 27 proprietary products in the U.S. and approximately 1,025 products globally outside of the U.S. For more information, visit http://www.barrlabs.com.

Forward-Looking Statements

Except for the historical information contained herein, the statements made in this press release constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements can be identified by their use of words such as "expects," "plans," "projects," "will," "may," "anticipates," "believes," "should," "intends," "estimates" and other words of similar meaning. Because such statements inherently involve risks and uncertainties that cannot be predicted or quantified, actual results may differ materially from those expressed or implied by such forward-looking statements depending upon a number of factors affecting the Company's business. These factors include, among others: the difficulty in predicting the timing and outcome of legal proceedings, including patent-related matters such as patent challenge settlements and
'/>"/>

SOURCE Barr Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

4

GOOD

Page: 1 2 3 4

Related biology technology :

1. Impact Systems Announces Completion of Successful Enterprise Content Migrations to Documentum 6
2. ValGenesis, Inc. Announces Worldwide Release of Validation Life Cycle Management System - ValGenesis 2.0
3. Wyeth Pharmaceuticals Announces Organizational Change
4. Spectral announces continuing support for the combination of EAA(TM) and anti-endotoxin therapeutics
5. Pinnacle Biologics Announces Stock Purchase Agreement With MedImmune
6. Cell Biosciences Announces New Leadership
7. Rosetta Genomics Announces Plans to Recruit a New Chief Financial Officer
8. BioNeutral Laboratories Announces the Appointment of Stephen Browand as a Director to Head Military, Homeland Security and Governmental Affairs
9. Lixte Biotechnology Holdings Announces Extension of Its Cooperative Research and Development Agreement With The National Institute of Neurological Disorders and Stroke, National Institutes of Health, for Development of Anti-Brain Cancer Drugs
10. SciQuest Announces Newest Life Sciences Customer; BioMarin Pharmaceutical Drives Spending Effectiveness with Automated, Intuitive Procurement
11. Quest PharmaTech Announces Interim Results from Phase I/II Clinical Trial for Photodynamic Treatment for Hair Removal
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... LONDON, Dec. 15 Thomson ... Pharma ® has become the first drug pipeline ... and outcome information. This highly anticipated new content ... this month. ,, Thomson Pharma ... from registries, publications, press releases, conferences, and other ...
(Date:12/14/2009)... JUPITER, Fla., Dec. 14 Dyadic International, ... it has extended its collaboration with The Scripps ... with Scripps to re-annotate the genome of Dyadic,s ... agreement is a continuation of the successful relationship ... 2006 when Dyadic engaged Scripps to annotate the ...
(Date:12/14/2009)... Nektar Therapeutics (Nasdaq: NKTR ) announced today ... on its board of directors. Winger is ... years of experience in corporate management, financial and ... industry perspective at an important time in the ... CEO of Nektar and member of the Board ...
(Date:12/11/2009)... Dendreon Corporation (Nasdaq: DNDN ) ... announced public offering have exercised in full their ... common stock at the public offering price of ... option increases the size of the offering to ... Dendreon expects to receive net proceeds from ...
Breaking Biology Technology:Thomson Reuters is First to Offer Fully Integrated Pipeline and Clinical Trials 2Dyadic International Extends Collaboration With The Scripps Research Institute 2Dyadic International Extends Collaboration With The Scripps Research Institute 3Dyadic International Extends Collaboration With The Scripps Research Institute 4Dyadic International Extends Collaboration With The Scripps Research Institute 5Dennis Winger Joins Nektar Therapeutics' Board of Directors 2Dennis Winger Joins Nektar Therapeutics' Board of Directors 3Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering 2Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering 3
... , , , ... This Application Note describes how Gene Logic, Inc., has ... by using,the Agilent 2100 bioanalyzer. The Eukaryote Total RNA Nano and Pico,assays ... as well as detection of possible degradation. The mRNA Smear,Nano assay is ...
... , ... , , , ... is the major,cause of chronic active gastritis,and is associated with ... PCR (mPCR) based,approach distinguished different,allelic variants that are associated,with different ...
... , ... , , , ... as research tools,(for example protein arrays) or as biopharmaceutical therapeutics. ... quality control. The key quality criteria include: protein identification,quantitation and ...
Other Biology Technology:Advancing the quality control methodology,to assess isolated total RNA,and generated fragmented cRNA 2Advancing the quality control methodology,to assess isolated total RNA,and generated fragmented cRNA 3Advancing the quality control methodology,to assess isolated total RNA,and generated fragmented cRNA 4Advancing the quality control methodology,to assess isolated total RNA,and generated fragmented cRNA 5Advancing the quality control methodology,to assess isolated total RNA,and generated fragmented cRNA 6Microfluidic analysis of multiplex,PCR products for the genotyping of,Helicobacter pylori 2Microfluidic analysis of multiplex,PCR products for the genotyping of,Helicobacter pylori 3Microfluidic analysis of multiplex,PCR products for the genotyping of,Helicobacter pylori 4Microfluidic analysis of multiplex,PCR products for the genotyping of,Helicobacter pylori 5Microfluidic analysis of multiplex,PCR products for the genotyping of,Helicobacter pylori 6Quality control of antibodies using the,2100 bioanalyzer and the Protein 200,Plus assay 2Quality control of antibodies using the,2100 bioanalyzer and the Protein 200,Plus assay 3
(Date:12/14/2009)... a clean-burning, renewable fuel that could help wean the ... by ozone, compared with gasoline, especially in winter, according ... , Ozone production from both gasoline and E85, a ... ethanol, is greater in warm sunny weather than during ... heat and sunlight contribute to ozone formation. But E85 ...
(Date:12/14/2009)... are spending the holidays with big Uncle Frank or ... better off with another family, spare a thought for ... from McMaster University and the University of New South ... lives in groups, members make strategic decisions about their ... current issue of Biology Letters . , The ...
(Date:12/14/2009)... Technology Partners, a global software company that automates ... the Pharmaceutical industry, today announced the general availability ... data acquisition platform. The latest release enables quality ... manufacturing processes. ,, MODA 3.0 includes the ... Methods: Each test method in the MODA ...
Breaking Biology News(10 mins):Ethanol-powered vehicles generate more ozone than gas-powered ones 2Ethanol-powered vehicles generate more ozone than gas-powered ones 3MODA Announces Availability of Third Generation Mobile Data Acquisition Platform 2One in 10 High School Seniors Have Used Narcotic Painkillers 53538 1One in 10 High School Seniors Have Used Narcotic Painkillers 53538 2One in 10 High School Seniors Have Used Narcotic Painkillers 53538 3Researchers Identify New Method to Selectively Kill Metastatic Melanoma Cells 53536 1Researchers Identify New Method to Selectively Kill Metastatic Melanoma Cells 53536 2Researchers Identify New Method to Selectively Kill Metastatic Melanoma Cells 53536 3Larry Schreiber Named President of Anthem Blue Cross and Blue Shield in Wisconsin 53534 1Larry Schreiber Named President of Anthem Blue Cross and Blue Shield in Wisconsin 53534 2
... therapeutic cancer vaccine combining the synthetic bacterial DNA sequence, ... were reported today in the Journal of Clinical Investigation. ... is safe, and increases the immune system's ability to ... was conducted by the Lausanne Branch of the Ludwig ...
... , ,Oncologists have long thought that cancer ... of day. But they have been unable to turn ... the phenomenon well enough. Now, researchers have discovered a ... changes with the clock. They said their findings could ...
... Expression Project for Oncology (expO) has released clinically ... completing the initial phase of the nation’s first ... gene expression data. The clinically annotated dataset is ... Center for Biotechnology Information web site at www.ncbi.nlm.nih.gov/geo/. ...
Other Biology News:Pathogen-Mimicking Vaccine As Strategy For Cancer Therapy 2Effective Cancer Treatments Follow The Clock 2Effective Cancer Treatments Follow The Clock 3Expression Project for Oncology (expO) completes first phase of standardized gene expression analyses 2Expression Project for Oncology (expO) completes first phase of standardized gene expression analyses 3
...
... TURRAX Tube Disperser System from IKA Works is ... a cleaner, safer, and more efficient way to ... from 2 to 15 ml inside sealed tubes. ... one of 4 different tube types. Each tube ...
...
... light scattering detector for ambient HPLC. ... processing hardware for two external devices ... Also contains an analog output from ... strip chart recorders. Includes an input ...
Biology Products: